Cargando…

Reducing transmission of SARS-CoV-2 with intranasal prophylaxis

Detalles Bibliográficos
Autores principales:	Boiardi, Federico, Stebbing, Justin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	In Focus
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750542/ https://www.ncbi.nlm.nih.gov/pubmed/33340994 http://dx.doi.org/10.1016/j.ebiom.2020.103170

Ejemplares similares

The role of airborne particles and environmental considerations in the transmission of SARS-CoV-2
por: Shao, Longyi, et al.
Publicado: (2021)

German and international studies on SARS-CoV-2 seroprevalence
por: Poethko-Müller, Christina, et al.
Publicado: (2020)

Possible modes of transmission of Novel Coronavirus SARS-CoV-2: a review
por: Mukhra, Richa, et al.
Publicado: (2020)

Exploring the emergence of vertical transmission of SARS-CoV-2: A Rapid Review
por: Jain, Vidhi, et al.
Publicado: (2020)

Sports balls as potential SARS-CoV-2 transmission vectors
por: Pelisser, Michel, et al.
Publicado: (2020)

SARS-CoV-2 transmission in the Lombardy Region: the increase of household contagion and its implication for containment measures
por: Signorelli, Carlo, et al.
Publicado: (2020)

SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings
por: Williams, Phoebe C.M., et al.
Publicado: (2020)

SARS-CoV2 and mitochondria: the impact on cell fate
por: Madeddu, Eleonora, et al.
Publicado: (2022)

Developments in paediatric cancer care throughout the COVID-19 pandemic: Lessons from China
por: Boiardi, Federico, et al.
Publicado: (2022)

An intranasal ASO therapeutic targeting SARS-CoV-2
por: Zhu, Chi, et al.
Publicado: (2022)

Socioeconomic inequalities in the risk of SARS-CoV-2 infection – First results from an analysis of surveillance data from Germany
por: Wachtler, Benjamin, et al.
Publicado: (2020)

SARS-CoV-2 Infection in patients with cystic fibrosis. An overwiew
por: Fainardi, Valentina, et al.
Publicado: (2020)

What is the intermediate host species of SARS-CoV-2?
por: Friend, Thomas, et al.
Publicado: (2021)

Seroepidemiological study on the spread of SARS-CoV-2 in populations in especially affected areas in Germany – Study protocol of the CORONA-MONITORING lokal study
por: Santos-Hövener, Claudia, et al.
Publicado: (2020)

Antigen Detection Tests for SARS-CoV-2: a systematic review and meta-analysis on real world data
por: Riccò, Matteo, et al.
Publicado: (2022)

New variant of SARS-CoV-2 in UK causes surge of COVID-19
por: Kirby, Tony
Publicado: (2021)

Occurrence of SARS-CoV-2 infection among healthcare personnel: results from an early systematic review and meta-analysis
por: Riccò, Matteo, et al.
Publicado: (2021)

SARS-CoV-2 (COVID-19) superspreader events
por: Majra, Dasha, et al.
Publicado: (2021)

SARS-CoV-2 Omicron (B.1.1.529) Variant: No Time to Wait!
por: Rahmani, Shayan, et al.
Publicado: (2022)

Intranasal fusion inhibitory lipopeptide prevents direct contact SARS-CoV-2 transmission in ferrets
por: de Vries, Rory D., et al.
Publicado: (2020)

Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets
por: de Vries, Rory D., et al.
Publicado: (2021)

Intranasal SARS-CoV-2 Vaccines: Indispensable and Inevitable
por: Adashi, Eli Y., et al.
Publicado: (2022)

The “perfect” storm: Current evidence on pediatric inflammatory multisystem disease during SARS-CoV-2 pandemic
por: Lami, Francesca, et al.
Publicado: (2020)

Protection against SARS-CoV-2 transmission by a parenteral prime—Intranasal boost vaccine strategy
por: Christensen, Dennis, et al.
Publicado: (2022)

Repurposing Fostamatinib to Combat SARS-CoV-2-Induced Acute Lung Injury
por: Tabassum, Neha, et al.
Publicado: (2020)

Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model
por: Langel, Stephanie N., et al.
Publicado: (2022)

Intravenous, Intratracheal, and Intranasal Inoculation of Swine with SARS-CoV-2
por: Buckley, Alexandra, et al.
Publicado: (2021)

RNA–protein interactomes as invaluable resources to study RNA viruses: Insights from SARS CoV‐2 studies
por: Koliński, Marcin, et al.
Publicado: (2022)

Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters
por: Vesin, Benjamin, et al.
Publicado: (2022)

Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now)
por: Riccò, Matteo, et al.
Publicado: (2020)

Facial Surgery in the Era of SARS-CoV-2 and Beyond: Challenges, Considerations, and Initiatives
por: DiCaro, Michael V., et al.
Publicado: (2020)

Correction to: Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Intranasal gene therapy to prevent infection by SARS-CoV-2 variants
por: Sims, Joshua J., et al.
Publicado: (2021)

Does hand hygiene reduce SARS-CoV-2 transmission?
por: Yang, Chao
Publicado: (2020)

Reducing Aerosol Transmission of SARS-CoV-2 in Craniomaxillofacial Osteosynthesis
por: Arakeri, Gururaj, et al.
Publicado: (2020)

Defining SARS-CoV-2 breakthrough infection needing hospitalization in mass vaccination era: from disease-centered to patient-centered care
por: Ticinesi, Andrea, et al.
Publicado: (2022)

Production of ORF8 protein from SARS-CoV-2 using an inducible virus-mediated expression system in suspension-cultured tobacco BY-2 cells
por: Imamura, Tomohiro, et al.
Publicado: (2021)

Intranasal or airborne transmission-mediated delivery of an attenuated SARS-CoV-2 protects Syrian hamsters against new variants
por: Stauft, Charles B., et al.
Publicado: (2023)

Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques
por: Yu, Jingyou, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_36barog116jmuck3k7i9lt603o